Suppr超能文献

针对纤维肌痛成人患者的有氧运动训练

Aerobic exercise training for adults with fibromyalgia.

作者信息

Bidonde Julia, Busch Angela J, Schachter Candice L, Overend Tom J, Kim Soo Y, Góes Suelen M, Boden Catherine, Foulds Heather Ja

机构信息

Norwegian Institute of Public Health, PO Box 4404 Nydalen, Oslo, Norway, 0403.

出版信息

Cochrane Database Syst Rev. 2017 Jun 21;6(6):CD012700. doi: 10.1002/14651858.CD012700.

Abstract

BACKGROUND

Exercise training is commonly recommended for individuals with fibromyalgia. This review is one of a series of reviews about exercise training for people with fibromyalgia that will replace the "Exercise for treating fibromyalgia syndrome" review first published in 2002.

OBJECTIVES

• To evaluate the benefits and harms of aerobic exercise training for adults with fibromyalgia• To assess the following specific comparisons ० Aerobic versus control conditions (eg, treatment as usual, wait list control, physical activity as usual) ० Aerobic versus aerobic interventions (eg, running vs brisk walking) ० Aerobic versus non-exercise interventions (eg, medications, education) We did not assess specific comparisons involving aerobic exercise versus other exercise interventions (eg, resistance exercise, aquatic exercise, flexibility exercise, mixed exercise). Other systematic reviews have examined or will examine these comparisons (Bidonde 2014; Busch 2013).

SEARCH METHODS

We searched the Cochrane Library, MEDLINE, Embase, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), the Physiotherapy Evidence Database (PEDro), Thesis and Dissertation Abstracts, the Allied and Complementary Medicine Database (AMED), the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP), and the ClinicalTrials.gov registry up to June 2016, unrestricted by language, and we reviewed the reference lists of retrieved trials to identify potentially relevant trials.

SELECTION CRITERIA

We included randomized controlled trials (RCTs) in adults with a diagnosis of fibromyalgia that compared aerobic training interventions (dynamic physical activity that increases breathing and heart rate to submaximal levels for a prolonged period) versus no exercise or another intervention. Major outcomes were health-related quality of life (HRQL), pain intensity, stiffness, fatigue, physical function, withdrawals, and adverse events.

DATA COLLECTION AND ANALYSIS

Two review authors independently selected trials for inclusion, extracted data, performed a risk of bias assessment, and assessed the quality of the body of evidence for major outcomes using the GRADE approach. We used a 15% threshold for calculation of clinically relevant differences between groups.

MAIN RESULTS

We included 13 RCTs (839 people). Studies were at risk of selection, performance, and detection bias (owing to lack of blinding for self-reported outcomes) and had low risk of attrition and reporting bias. We prioritized the findings when aerobic exercise was compared with no exercise control and present them fully here.Eight trials (with 456 participants) provided low-quality evidence for pain intensity, fatigue, stiffness, and physical function; and moderate-quality evidence for withdrawals and HRQL at completion of the intervention (6 to 24 weeks). With the exception of withdrawals and adverse events, major outcome measures were self-reported and were expressed on a 0 to 100 scale (lower values are best, negative mean differences (MDs)/standardized mean differences (SMDs) indicate improvement). Effects for aerobic exercise versus control were as follows: HRQL: mean 56.08; five studies; N = 372; MD -7.89, 95% CI -13.23 to -2.55; absolute improvement of 8% (3% to 13%) and relative improvement of 15% (5% to 24%); pain intensity: mean 65.31; six studies; N = 351; MD -11.06, 95% CI -18.34 to -3.77; absolute improvement of 11% (95% CI 4% to 18%) and relative improvement of 18% (7% to 30%); stiffness: mean 69; one study; N = 143; MD -7.96, 95% CI -14.95 to -0.97; absolute difference in improvement of 8% (1% to 15%) and relative change in improvement of 11.4% (21.4% to 1.4%); physical function: mean 38.32; three studies; N = 246; MD -10.16, 95% CI -15.39 to -4.94; absolute change in improvement of 10% (15% to 5%) and relative change in improvement of 21.9% (33% to 11%); and fatigue: mean 68; three studies; N = 286; MD -6.48, 95% CI -14.33 to 1.38; absolute change in improvement of 6% (12% improvement to 0.3% worse) and relative change in improvement of 8% (16% improvement to 0.4% worse). Pooled analysis resulted in a risk ratio (RR) of moderate quality for withdrawals (17 per 100 and 20 per 100 in control and intervention groups, respectively; eight studies; N = 456; RR 1.25, 95%CI 0.89 to 1.77; absolute change of 5% more withdrawals with exercise (3% fewer to 12% more).Three trials provided low-quality evidence on long-term effects (24 to 208 weeks post intervention) and reported that benefits for pain and function persisted but did not for HRQL or fatigue. Withdrawals were similar, and investigators did not assess stiffness and adverse events.We are uncertain about the effects of one aerobic intervention versus another, as the evidence was of low to very low quality and was derived from single trials only, precluding meta-analyses. Similarly, we are uncertain of the effects of aerobic exercise over active controls (ie, education, three studies; stress management training, one study; medication, one study) owing to evidence of low to very low quality provided by single trials. Most studies did not measure adverse events; thus we are uncertain about the risk of adverse events associated with aerobic exercise.

AUTHORS' CONCLUSIONS: When compared with control, moderate-quality evidence indicates that aerobic exercise probably improves HRQL and all-cause withdrawal, and low-quality evidence suggests that aerobic exercise may slightly decrease pain intensity, may slightly improve physical function, and may lead to little difference in fatigue and stiffness. Three of the reported outcomes reached clinical significance (HRQL, physical function, and pain). Long-term effects of aerobic exercise may include little or no difference in pain, physical function, and all-cause withdrawal, and we are uncertain about long-term effects on remaining outcomes. We downgraded the evidence owing to the small number of included trials and participants across trials, and because of issues related to unclear and high risks of bias (performance, selection, and detection biases). Aerobic exercise appears to be well tolerated (similar withdrawal rates across groups), although evidence on adverse events is scarce, so we are uncertain about its safety.

摘要

背景

运动训练通常被推荐给纤维肌痛患者。本综述是关于纤维肌痛患者运动训练的一系列综述之一,将取代2002年首次发表的“运动治疗纤维肌痛综合征”综述。

目的

• 评估有氧运动训练对成年纤维肌痛患者的益处和危害• 评估以下具体比较:有氧训练与对照条件(如常规治疗、等待名单对照、常规身体活动);有氧训练与有氧干预(如跑步与快走);有氧训练与非运动干预(如药物治疗、教育)。我们未评估涉及有氧运动与其他运动干预(如抗阻运动、水上运动、柔韧性运动、混合运动)的具体比较。其他系统评价已对或将会对这些比较进行研究(Bidonde 2014;Busch 2013)。

检索方法

我们检索了Cochrane图书馆、MEDLINE、Embase、护理学与健康相关文献累积索引(CINAHL)、物理治疗证据数据库(PEDro)、学位论文摘要、补充与替代医学数据库(AMED)、世界卫生组织国际临床试验注册平台(WHO ICTRP)以及ClinicalTrials.gov注册库,检索截至2016年6月,不受语言限制,并查阅了检索到的试验的参考文献列表以识别潜在相关试验。

选择标准

我们纳入了诊断为纤维肌痛的成年患者的随机对照试验(RCT),这些试验比较了有氧训练干预(能使呼吸和心率在较长时间内增加至次最大水平的动态身体活动)与无运动或其他干预。主要结局包括健康相关生活质量(HRQL)、疼痛强度、僵硬程度、疲劳、身体功能、退出试验情况及不良事件。

数据收集与分析

两位综述作者独立选择纳入试验、提取数据、进行偏倚风险评估,并使用GRADE方法评估主要结局的证据质量。我们使用15%的阈值来计算组间临床相关差异。

主要结果

我们纳入了13项RCT(839人)。研究存在选择、实施和检测偏倚风险(由于自我报告结局缺乏盲法),而失访和报告偏倚风险较低。当将有氧运动与无运动对照进行比较时,我们对结果进行了优先排序并在此完整呈现。八项试验(456名参与者)为干预结束时(6至24周)的疼痛强度、疲劳、僵硬程度和身体功能提供了低质量证据;为退出试验情况和HRQL提供了中等质量证据。除退出试验情况和不良事件外,主要结局指标均为自我报告,以0至100分表示(分数越低越好,负的均值差(MDs)/标准化均值差(SMDs)表示改善)。有氧运动与对照的效果如下:HRQL:均值56.08;五项研究;N = 372;MD -7.89,95%CI -13.23至-2.55;绝对改善率8%(3%至13%),相对改善率15%(5%至24%);疼痛强度:均值65.31;六项研究;N = 351;MD -11.06,95%CI -18.34至-3.77;绝对改善率11%(95%CI 4%至18%),相对改善率18%(7%至30%);僵硬程度:均值69;一项研究;N = 143;MD -7.96,95%CI -14.95至-0.97;改善的绝对差异8%(1%至15%),改善的相对变化11.4%(21.4%至1.4%);身体功能:均值38.32;三项研究;N = 246;MD -10.16,95%CI -15.39至-4.94;改善的绝对变化10%(15%至5%),改善的相对变化21.9%(33%至11%);疲劳:均值68;三项研究;N = 286;MD -6.48,95%CI -14.33至1.38;改善的绝对变化6%(改善12%至恶化0.3%),改善的相对变化8%(改善16%至恶化0.4%)。汇总分析得出退出试验情况的风险比(RR)为中等质量(对照组和干预组分别为每100人中有17人和20人退出;八项研究;N = 456;RR 1.25,95%CI 0.89至1.77;运动导致退出试验人数绝对增加5%(减少3%至增加12%))。三项试验为长期效果(干预后24至208周)提供了低质量证据,并报告疼痛和功能方面的益处持续存在,但HRQL或疲劳方面没有。退出试验情况相似,研究人员未评估僵硬程度和不良事件。由于证据质量低至极低且仅来自单个试验,排除进行荟萃分析,我们不确定一种有氧干预与另一种有氧干预的效果。同样,由于单个试验提供的证据质量低至极低,我们不确定有氧运动与积极对照(即教育,三项研究;压力管理训练,一项研究;药物治疗,一项研究)相比的效果。大多数研究未测量不良事件;因此,我们不确定与有氧运动相关的不良事件风险。

作者结论

与对照相比,中等质量证据表明有氧运动可能改善HRQL和全因退出试验情况,低质量证据表明有氧运动可能轻微降低疼痛强度,可能轻微改善身体功能,且可能在疲劳和僵硬程度方面导致差异不大。报告的三项结局达到临床意义(HRQL、身体功能和疼痛)。有氧运动的长期效果可能包括疼痛、身体功能和全因退出试验情况方面差异很小或无差异,我们不确定对其余结局的长期效果。由于纳入试验数量少以及各试验参与者数量少,且存在与偏倚不明确和高风险(实施、选择和检测偏倚)相关的问题,我们对证据进行了降级。有氧运动似乎耐受性良好(各组退出试验率相似),尽管关于不良事件的证据很少,所以我们不确定其安全性。

相似文献

1
Aerobic exercise training for adults with fibromyalgia.针对纤维肌痛成人患者的有氧运动训练
Cochrane Database Syst Rev. 2017 Jun 21;6(6):CD012700. doi: 10.1002/14651858.CD012700.
2
Whole body vibration exercise training for fibromyalgia.纤维肌痛的全身振动运动训练
Cochrane Database Syst Rev. 2017 Sep 26;9(9):CD011755. doi: 10.1002/14651858.CD011755.pub2.
3
Exercise for hand osteoarthritis.手部骨关节炎的运动疗法
Cochrane Database Syst Rev. 2017 Jan 31;1(1):CD010388. doi: 10.1002/14651858.CD010388.pub2.
4
Mixed exercise training for adults with fibromyalgia.针对纤维肌痛成人患者的混合运动训练
Cochrane Database Syst Rev. 2019 May 24;5(5):CD013340. doi: 10.1002/14651858.CD013340.
6
Physical activity for treatment of irritable bowel syndrome.体力活动治疗肠易激综合征。
Cochrane Database Syst Rev. 2022 Jun 29;6(6):CD011497. doi: 10.1002/14651858.CD011497.pub2.
7
Pulmonary rehabilitation versus usual care for adults with asthma.肺康复治疗与常规护理对哮喘成人的影响比较。
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD013485. doi: 10.1002/14651858.CD013485.pub2.
8
Exercise therapy for chronic fatigue syndrome.慢性疲劳综合征的运动疗法
Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD003200. doi: 10.1002/14651858.CD003200.pub7.
9
Celecoxib for osteoarthritis.塞来昔布用于骨关节炎
Cochrane Database Syst Rev. 2017 May 22;5(5):CD009865. doi: 10.1002/14651858.CD009865.pub2.
10
Yoga treatment for chronic non-specific low back pain.瑜伽治疗慢性非特异性下腰痛。
Cochrane Database Syst Rev. 2017 Jan 12;1(1):CD010671. doi: 10.1002/14651858.CD010671.pub2.

引用本文的文献

3
Fibromyalgia: do I tackle you with complementary medicines?纤维肌痛:我要用辅助药物来对付你吗?
Pain Rep. 2025 Jun 25;10(4):e1278. doi: 10.1097/PR9.0000000000001278. eCollection 2025 Aug.
4
Physical Modalities for the Treatment of Pain in Patients with Fibromyalgia.用于治疗纤维肌痛患者疼痛的物理治疗方法。
Mediterr J Rheumatol. 2025 Mar 31;36(1):12-27. doi: 10.31138/mjr.041124.pht. eCollection 2025 Mar.

本文引用的文献

3
EULAR revised recommendations for the management of fibromyalgia.EULAR 修订的纤维肌痛管理建议。
Ann Rheum Dis. 2017 Feb;76(2):318-328. doi: 10.1136/annrheumdis-2016-209724. Epub 2016 Jul 4.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验